Cargando…
Advances in Cancer Immunotherapy in Solid Tumors
Immunotherapy is heralded as one of the most important advances in oncology. Until recently, only limited immunotherapeutic options were available in selected immunogenic cancers like melanoma and renal cell carcinomas. Nowadays, there is an improved understanding that anti-tumor immunity is control...
Autores principales: | Menon, Smitha, Shin, Sarah, Dy, Grace |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5187504/ https://www.ncbi.nlm.nih.gov/pubmed/27886124 http://dx.doi.org/10.3390/cancers8120106 |
Ejemplares similares
-
Alterations in genes other than EGFR/ALK/ROS1 in non-small cell lung cancer: trials and treatment options
por: Desai, Arpita, et al.
Publicado: (2016) -
Recent Advances in CAR-Based Solid Tumor Immunotherapy
por: Shin, Min Hwa, et al.
Publicado: (2023) -
Systematic review of combinations of targeted or immunotherapy in advanced solid tumors
por: Tan, Aaron C, et al.
Publicado: (2021) -
Combination Immunotherapy Using Oncolytic Virus for the Treatment of Advanced Solid Tumors
por: Oh, Chang-Myung, et al.
Publicado: (2020) -
Challenges and Recent Advances in NK Cell-Targeted Immunotherapies in Solid Tumors
por: Lian, Guangyu, et al.
Publicado: (2021)